Endoscopic Ultrasound (EUS) Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)
The global Endoscopic Ultrasound (EUS) Market size is forecast to increase from $1.86 Billion in 2026 to $3.18 Billion in 2034 at a CAGR of 6.95% between 2026 and 2034.
The Endoscopic Ultrasound (EUS) market report provides detailed analysis and outlook of Endoscopic Ultrasound (EUS) segments including By Product Type (Endoscopes, Ultrasound Processors, EUS Needles, EUS Procedure Kits and Accessories), By Procedure Type (Diagnostic Procedures, Therapeutic Procedures), By Application (Oncology, Gastrointestinal Disorders, Pulmonary Diseases, Other Applications ), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Endoscopic Ultrasound (EUS) Industry Overview: Advanced Imaging Workstations and Therapeutic Expansion in Gastrointestinal Oncology
Expanded EUS Platforms Enhancing Precision Tissue Sampling in GI Disease
The endoscopic ultrasound (EUS) industry is advancing through the expansion of high-resolution imaging platforms and precision biopsy technologies for gastrointestinal and hepatobiliary disease diagnosis. Olympus has showcased its expanded EUS portfolio, including the Aplio i800 EUS Ultrasound System in collaboration with Canon, along with the SecureFlex™ fine-needle biopsy (FNB) system. These technologies are designed to improve diagnostic accuracy in pancreatic and liver diseases by enabling more precise tissue sampling. The integration of advanced imaging and biopsy tools is strengthening early disease detection and improving diagnostic yield in complex gastrointestinal oncology workflows.
Interventional EUS Training Driving Expansion of Therapeutic Applications
Clinical training programs led by professional societies such as the American Society for Gastrointestinal Endoscopy (ASGE) are accelerating the adoption of advanced interventional EUS techniques. Specialized hands-on training in 2026 focuses on complex procedures including biliary drainage, gastroenterostomy, and ablation of pancreatic cysts and tumors. This reflects a broader industry shift from purely diagnostic applications toward minimally invasive therapeutic interventions. The growing expertise in interventional EUS is expanding its clinical utility in managing advanced gastrointestinal and pancreatic diseases, positioning it as a key modality in endoscopic oncology treatment pathways.
Integrated Imaging Workstations Supporting Multi-Organ Diagnostic Capabilities
The industry is moving toward multifunctional ultrasound workstations that integrate endoscopic and endobronchial imaging capabilities into a single platform. Systems such as the Olympus EU-ME3 ultrasound processor combine gastrointestinal and pulmonary ultrasound functionalities, enabling cross-specialty diagnostic and interventional procedures. This convergence improves workflow efficiency and supports comprehensive imaging assessments across multiple organ systems. The integration of multi-modal ultrasound platforms is enhancing diagnostic versatility and expanding the role of EUS technology in both gastroenterology and respiratory medicine.
Endoscopic Ultrasound (EUS) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Endoscopic Ultrasound (EUS) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Fujifilm Holdings Corporation, PENTAX Medical (HOYA Corporation), Cook Medical, CONMED Corporation, CANON MEDICAL SYSTEMS CORPORATION, SonoScape Medical Corp., Micro-Tech Endoscopy. The Endoscopic Ultrasound (EUS) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Endoscopic Ultrasound (EUS) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
-
Growth Endoscopic Ultrasound (EUS) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
-
Market Trends, Drivers, Potential Opportunities, and Challenges faced by Endoscopic Ultrasound (EUS) companies
-
Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
-
Detailed SWOT Analysis of global and regional Endoscopic Ultrasound (EUS) markets
-
Competitive analysis including business description, product analysis, and financial profiles
-
Key country specific analysis detailing key factors shaping the short-term and long-term outlook
-
Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Endoscopic Ultrasound (EUS) Market Competitive Benchmarking and Company Analysis
Leading companies in Endoscopic Ultrasound (EUS) industry include- Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Fujifilm Holdings Corporation, PENTAX Medical (HOYA Corporation), Cook Medical, CONMED Corporation, CANON MEDICAL SYSTEMS CORPORATION, SonoScape Medical Corp., Micro-Tech Endoscopy. The Endoscopic Ultrasound (EUS) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Endoscopic Ultrasound (EUS) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Endoscopic Ultrasound (EUS) market remains one of the strongest-performing segments in the country.
The US Endoscopic Ultrasound (EUS) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Endoscopic Ultrasound (EUS) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Endoscopic Ultrasound (EUS) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Endoscopic Ultrasound (EUS) markets
Canada's strong Endoscopic Ultrasound (EUS) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Endoscopic Ultrasound (EUS) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Endoscopic Ultrasound (EUS) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Endoscopic Ultrasound (EUS) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Endoscopic Ultrasound (EUS) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Endoscopic Ultrasound (EUS) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Endoscopic Ultrasound (EUS) market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Endoscopic Ultrasound (EUS) sales through 2034
France Endoscopic Ultrasound (EUS) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Endoscopic Ultrasound (EUS) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Endoscopic Ultrasound (EUS) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Endoscopic Ultrasound (EUS) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Endoscopic Ultrasound (EUS) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Endoscopic Ultrasound (EUS) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Endoscopic Ultrasound (EUS) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Endoscopic Ultrasound (EUS) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Endoscopic Ultrasound (EUS) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Endoscopic Ultrasound (EUS) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Endoscopic Ultrasound (EUS) Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Endoscopic Ultrasound (EUS) Market Segmentation
By Product Type
Endoscopes
Ultrasound Processors
EUS Needles
EUS Procedure Kits and Accessories
By Procedure Type
Diagnostic Procedures
Therapeutic Procedures
By Application
Oncology
Gastrointestinal Disorders
Pulmonary Diseases
Other Applications
By End-User
Hospitals
Specialty Clinics
Diagnostic Centers
Academic and Research Institutes
Top Companies in Endoscopic Ultrasound (EUS) Industry
Olympus Corporation
Boston Scientific Corporation
Medtronic plc
Fujifilm Holdings Corporation
PENTAX Medical (HOYA Corporation)
Cook Medical
CONMED Corporation
CANON MEDICAL SYSTEMS CORPORATION
SonoScape Medical Corp.
Micro-Tech Endoscopy
Countries Included
-
North America- US, Canada, Mexico
-
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
-
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
-
Latin America- Brazil, Argentina, Others
-
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Latest Market Updates In Healthcare
Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.
Low MOQ, High-Mix Production Models for Indie & DTC Brands
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
Market UpdateRise of Functional and Clinical-Grade Skincare
The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...
By Product Type
Endoscopes
Ultrasound Processors
EUS Needles
EUS Procedure Kits and Accessories
By Procedure Type
Diagnostic Procedures
Therapeutic Procedures
By Application
Oncology
Gastrointestinal Disorders
Pulmonary Diseases
Other Applications
By End-User
Hospitals
Specialty Clinics
Diagnostic Centers
Academic and Research Institutes